Literature DB >> 10372652

Cocaethylene formation in rat, dog, and human hepatic microsomes.

N Song1, R B Parker, S C Laizure.   

Abstract

The dog and rat are important animal models for studying the role of cocaethylene in the pharmacodynamic interaction between cocaine and ethanol. In a previous study in our laboratory it was found that a cocaine dose of 3 mg/kg IV and ethanol 1 g/kg IV failed to produce detectable concentrations of cocaethylene in the plasma of dogs. In follow up to this result, the pharmacokinetic disposition of cocaine and cocaethylene in the dog were determined to be similar. These results suggested significant differences between animal and human cocaethylene formation may occur. To test this possibility the in vitro formation of cocaethylene was determined in rat, dog and human hepatic microsomal preparations containing cocaine (0-7 mM) and ethanol (50 mM). Nonlinear least-squares regression was used to estimate Km and Vmax and the results were compared statistically. The mean +/- standard deviation for Km and Vmax in the rat, dog and human were 0.53 +/- 0.04, 0.97 +/- 0.07, and 0.56 +/- 0.08 mM, and 390 +/- 9, 233 +/- 6, and 60 +/- 3 pmol/minute/mg protein, respectively. The Km in the dog was significantly greater (p<0.05) than the Km in the rat and human. The Vmax was statistically different among all three species (rat>dog>human; p<0.05). These results demonstrate that cocaethylene formation is greater in dog than human hepatic microsomes, which is in contrast to in vivo studies that appear to show that humans produce more cocaethylene than dogs. It is suggested by the authors that route of cocaine administration may be an important factor in the formation of cocaethylene when cocaine and ethanol are co-administered.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10372652     DOI: 10.1016/s0024-3205(99)00159-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Identification of alcohol-dependent clopidogrel metabolites using conventional liquid chromatography/triple quadrupole mass spectrometry.

Authors:  Zhe-Yi Hu; S Casey Laizure; Vanessa L Herring; Robert B Parker
Journal:  Rapid Commun Mass Spectrom       Date:  2014-06-15       Impact factor: 2.419

2.  Effects of alcohol on human carboxylesterase drug metabolism.

Authors:  Robert B Parker; Zhe-Yi Hu; Bernd Meibohm; S Casey Laizure
Journal:  Clin Pharmacokinet       Date:  2015-06       Impact factor: 6.447

3.  Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.

Authors:  S Casey Laizure; Robert B Parker; Vanessa L Herring; Zhe-Yi Hu
Journal:  Drug Metab Dispos       Date:  2013-11-08       Impact factor: 3.922

4.  The effect of ethanol on oral cocaine pharmacokinetics reveals an unrecognized class of ethanol-mediated drug interactions.

Authors:  Robert B Parker; S Casey Laizure
Journal:  Drug Metab Dispos       Date:  2009-11-17       Impact factor: 3.922

Review 5.  Vaccines against drugs of abuse: a viable treatment option?

Authors:  Kathleen M Kantak
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Kinetic characterization of human butyrylcholinesterase mutants for the hydrolysis of cocaethylene.

Authors:  Shurong Hou; Max Zhan; Xirong Zheng; Chang-Guo Zhan; Fang Zheng
Journal:  Biochem J       Date:  2014-06-15       Impact factor: 3.857

7.  Physiologically based pharmacokinetic modeling of impaired carboxylesterase-1 activity: effects on oseltamivir disposition.

Authors:  Zhe-Yi Hu; Andrea N Edginton; S Casey Laizure; Robert B Parker
Journal:  Clin Pharmacokinet       Date:  2014-09       Impact factor: 6.447

8.  Metabolic Enzymes of Cocaine Metabolite Benzoylecgonine.

Authors:  Xiabin Chen; Xirong Zheng; Max Zhan; Ziyuan Zhou; Chang-Guo Zhan; Fang Zheng
Journal:  ACS Chem Biol       Date:  2016-06-09       Impact factor: 5.100

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.